Anti-bacillus cereus antibacterial peptide as well as preparation method and application thereof
By designing the general formula of the new antimicrobial peptide amino acid sequence as [KR]GG[KR]XC[FWY]C[KR]X[KR][FWY]C[LIAV]CXG[KR][KR][KR][KR], the antimicrobial peptide XWC26 was solved The existing problems of low antibacterial activity and poor stability of antibacterial peptides have been achieved, and effective inhibition and stability improvement of Bacillus cereus is achieved, and is suitable for food preservatives and feed additives.
Patent Information
- Application Number
- CN202411101130.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-08-12
AI Technical Summary
The existing antibacterial peptides are difficult to effectively inhibit Bacillus cereus, resulting in high risk of food poisoning due to low antibacterial activity, poor stability and high toxicity.
A new type of antimicrobial peptide amino acid sequence design is [KR]GG[KR]XC[FWY]C[KR]X[KR][FWY]C[LIAV]CXG[KR][KR][KR][KR][KR][KR][KR][CTC resin is used as The solid phase carrier and Fmoc solid phase synthesis method synthesize antibacterial peptide XWC26, which strongly inhibits Bacillus cereus activity and has good stability.
Antibacterial peptide XWC26 has a strong inhibitory effect on Bacillus cereus, good stability, not easy to cause drug resistance, high synthesis efficiency and low production cost. It is suitable for the preparation of food preservatives and feed additives, effectively preventing cereus spores. Diseases caused by bacillus.
Smart Images

Figure CN118955637A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and specifically relates to the characterization, preparation and application of an artificially synthesized antimicrobial peptide against Bacillus cereus. Background Art
[0002] Bacillus cereus is a facultative anaerobic, spore-forming Gram-positive bacterium. It is a common foodborne pathogen that can produce enterotoxins, leading to diarrheal and vomiting food poisoning, and in severe cases, death. It is widely present in soil, dust, and water. It has relatively loose growth and reproduction conditions, and can produce defensive spores under harsh conditions. Therefore, Bacillus cereus contamination has been found in many pre-packaged foods, such as rice and flour products, dairy products, and meat products. Studies have found that when the number of Bacillus cereus in the ingested food is greater than 10 2 CFU / g (ml) has the risk of causing foodborne diseases, but it does not cause sensory changes, making it difficult for people to detect and therefore easy to eat by mistake. my country's dietary habits mainly focus on starch products such as rice and pasta, and there is a habit of eating leftovers and overnight meals, which has led to frequent food poisoning caused by Bacillus cereus. It is reported that among bacterial food poisoning in my country, food poisoning caused by Bacillus cereus ranks third in terms of both the number of occurrences and the number of people affected.
[0003] Antimicrobial peptides (AMPs) are a class of peptides that are widely found in nature. They have broad-spectrum antimicrobial activity and can quickly kill a variety of bacteria, fungi, viruses, and parasites. The extensive use of antibiotics has led to the emergence of drug-resistant bacteria, which has prompted people to devote themselves to the development of new antimicrobial agents. AMP is an excellent choice because of its unique biological activity and special mechanism of action that is different from traditional antibiotics. It has a good antibacterial effect on antibiotic-resistant bacteria. Therefore, AMP has become one of the most promising antibiotic substitutes, and its application in food, medicine, skin care products, and cosmetic preservatives is becoming more and more extensive, with good development prospects.
[0004] Although antimicrobial peptides have general advantages, they also have some obvious shortcomings. Some antimicrobial peptides have low antibacterial activity, poor stability, and high toxicity. Antimicrobial peptides obtained by modifying existing antimicrobial peptides or synthesizing them can greatly improve some of the above shortcomings to meet different application requirements, reduce dosage, and reduce costs. This study invented a class of synthetic antimicrobial peptides modified from host defense peptides, which have strong antibacterial effects and have low inhibitory concentrations against most bacteria. Summary of the invention
[0005] In order to overcome the shortcomings and deficiencies of the prior art, the purpose of the present invention is to provide a class of synthetic antimicrobial peptides that solve the problems in the above-mentioned background technology.
[0006] The purpose of the present invention is achieved through the following technical solutions:
[0007] A class of synthetic antimicrobial peptides whose amino acid sequence has the general formula [KR]GG[KR]XC[FWY]C[KR]X[KR][FWY]C[LIAV]CXG[KR][KR].
[0008] The expression [KR] in the brackets indicates that lysine and arginine are also acceptable at the first, fourth, ninth, eleventh, eighteenth and nineteenth positions in the grammar; [FWY] indicates that phenylalanine, tryptophan and tyrosine are also acceptable at the seventh and twelfth positions in the grammar; [LIAV] indicates that leucine, isoleucine, alanine and valine are also acceptable at the fourteenth position in the grammar. Further, the amino acid sequence of the anti-Bacillus cereus antimicrobial peptide is as follows:
[0009]
[0010]
[0011]
[0012] Furthermore, the molecular weight of the anti-Bacillus cereus antimicrobial peptide is in the range of 1907.36-2583.08 Da, the isoelectric point is in the range of 9.62-11.31, and the net charge number is in the range of 6-8.
[0013] Furthermore, the antimicrobial peptide XWC26 was synthesized, with the general formula of amino acid sequence KGGKLCWCKNKWCICLGKR, molecular weight of 2224.79 Da, isoelectric point of 9.70, and net charge number of 6.
[0014] The present invention provides an application of a class of synthetic antimicrobial peptides in the preparation of antimicrobial drugs, feed additives or food preservatives. The antimicrobial drugs, feed additives or food preservatives are used to inhibit and / or kill Bacillus cereus.
[0015] In the present invention, the anti-Bacillus cereus antimicrobial peptide is used in the preparation of a microbial inhibitor. The microbial inhibitor is a food preservative, a cosmetic preservative or a drug for preventing and treating bacterial infection. The microorganism is Bacillus cereus, and other Gram-positive bacteria and Gram-negative bacteria.
[0016] Another object of the present invention is to provide a method for preparing the above-mentioned synthetic antimicrobial peptide.
[0017] The invention discloses a method for synthesizing an antibacterial peptide against Bacillus cereus. The method adopts a CTC resin as a solid phase carrier and an Fmoc solid phase synthesis method to synthesize a peptide having an amino acid sequence of a target product.
[0018] Compared with the prior art, the present invention has the following beneficial effects:
[0019] The present invention designs and screens a class of polypeptides with a new amino acid sequence through bioinformatics technology. Experimental results show that the antimicrobial peptide XWC26 has a strong inhibitory effect on Bacillus cereus, has good stability, is not prone to drug resistance, has high synthesis efficiency and low production cost, and can be used to prepare feed additives or food preservatives for preventing diseases caused by Bacillus cereus. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 This is a diagram showing the cell morphology of Bacillus cereus after the antimicrobial peptide XWC26 acts on it.
[0021] Figure 2 This is a graph showing the inhibitory effect of the antimicrobial peptide XWC26 on the spore germination of Bacillus cereus.
[0022] Figure 3 This is a graph showing the test results of the hemolytic activity of the antimicrobial peptide XWC1.
[0023] Figure 4 This is a graph showing the bactericidal results of the antimicrobial peptide XWC26 in food samples. DETAILED DESCRIPTION
[0024] The specific implementation of the present invention is further described below in conjunction with examples, but the implementation and protection of the present invention are not limited thereto. It should be noted that if there are processes that are not particularly described in detail below, they can be implemented or understood by those skilled in the art with reference to the prior art. If the manufacturer of the reagents or instruments used is not indicated, they are deemed to be conventional products that can be purchased commercially.
[0025] Example 1: Design and screening of antimicrobial peptides
[0026] In view of the above-mentioned technical problems, the present invention designs and screens an antimicrobial peptide library with strong antibacterial activity that can effectively inhibit drug-resistant bacteria by modifying the sequence and spatial structure of the host defense peptide to a certain extent, and verifies the antibacterial activity.
[0027] The present invention is designed based on the following amino acid sequence formula:
[0028] [KR]GG[KR]XC[FWY]C[KR]X[KR][FWY]C[LIAV]CXG[KR][KR]
[0029] (The expression [KR] in brackets means that lysine and arginine are also acceptable in the first position in the syntax)
[0030] Table 1 Sequence list of antimicrobial peptides XCW1-XCW50
[0031]
[0032] Example 2: Synthesis of antimicrobial peptides
[0033] The antimicrobial peptide of the present invention is synthesized by conventional polypeptide solid phase synthesis. Taking the antimicrobial peptide XWC2 as an example, its sequence is: KGGKLCWCKWKYCICLGKR.
[0034] Sequence characteristics: The sequence type is amino acid sequence, containing 19 amino acid residues, with a molecular weight of 2273.89 Da and a net charge number of 6.
[0035] The specific synthesis steps are as follows: 1) Resin swelling: weigh 0.1mmol 2-ChlorotritylChloride Resin with a substitution degree, put the resin into a reaction tube, add DCM (15ml / g) solvent, and shake for 40min. 2) Connect the first amino acid: filter out the DCM solvent through a sand core, add 3 times the amount of Fmoc-Arg(Pbf)-OH amino acid of the resin substance, then add 2,4,6-trimethylpyridine, and finally add DCM to dissolve, shake for 12h, and wash with DMF 3 times. 3) Deprotection: add 10ml 20% piperidine DMF solution (15ml / g), shake for 6min, remove the piperidine DMF solution, add 10ml 20% piperidine DMF solution (15ml / g), and shake for 20min. 4) Detection: Drain the piperidine DMF solution, take a dozen resins, wash three times with ethanol, add one drop of ninhydrin and one drop of phenol solution, heat at 105℃~110℃ for 3min, and turn dark blue for positive reaction. 5) First washing: Wash three times with DMF (10ml / g) in sequence. 6) Blocking: Add methanol (10ml / g) and DIEA 3 times the amount of resin substance, shake for 20min, and wash three times with DMF. 7) Condensation (to produce the second amino acid Lysine in the sequence): Add Fmoc-Lys(boc)-OH amino acid, HCTU, and DIEA 3 times the amount of resin substance to the reaction tube, dissolve with as little DMF as possible, and react for 1h. 8) Second washing: Wash once with DMF (10ml / g) and twice with DMF (10ml / g) in sequence. 9) Repeat the above steps to connect the amino acids in the sequence from left to right. 10) After the last amino acid is connected, deprotection is performed and the resin is washed according to the following method: DMF (10 ml / g) twice, DCM (10 ml / g) twice, and drained for 8 minutes. 11) Cleavage of the peptide from the resin: The ratio of resin to cleavage solution is 10 ml / g, and constant temperature oscillation is performed for 150 minutes. (The cleavage solution is prepared according to volume percentage, which can be TFA95%, water 2.5%, TIS2.5%). 12) Blow-drying and washing: Blow the cleavage solution as dry as possible with nitrogen, chromatograph it with ether, wash it with ether six times, and then evaporate it at room temperature to obtain the crude peptide. 13) Analyze and identify the peptide using HPLC-MS: (1) Prepare a solution with a concentration of 1 mg / ml from the crude peptide. (2) Filter the dissolved solution with a 0.45 μm filter membrane. (3) Analysis: Take 10 μl and analyze it with HPLC-MS. The mobile phase is water and acetonitrile, the time is 25 minutes, the elution is isocratic, the HPLC is first balanced with an isocratic gradient for 5 minutes and then injected, the gradient is 40% water and 60% acetonitrile; the purity and MS identification are obtained. 13) The purified solution is freeze-dried to obtain the finished product. 14) The white powdery polypeptide is sealed and packaged and stored at -20 degrees.
[0036] Example 3: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) determination
[0037] The 50 antimicrobial peptides predicted and synthesized in Examples 1 and 2 that met the general formula were subjected to minimum inhibitory concentration (MIC) determination, and the peptides with the smallest MIC value and the strongest antimicrobial activity were screened out.
[0038] In this experiment, the model strain of Bacillus cereus ATCC14579 was selected as the test strain. Bacillus cereus was streaked onto a non-anti-MH solid medium and incubated at 37°C for 16 hours. 3 to 5 colonies were selected and inoculated into 3 mL of MH liquid medium for overnight culture. The next morning, the OD of the bacterial solution was measured using a spectrophotometer. 600 value and diluted it to 5 × 10 5 CFU / mL. Take 90μL of the diluted bacterial solution and add it to a 96-well plate. Dilute the antimicrobial peptide according to the two-fold dilution method and take 10μL of each and add them to the 96-well plate containing the bacterial suspension. The final concentrations are 128μg / mL, 64μg / mL, 32μg / mL, 16μg / mL, 8μg / mL, 4μg / mL, 2μg / mL, 1μg / mL, 0.5μg / mL, 0.25μg / mL, and ampicillin is used as a control. Place the 96-well plate in an incubator at 37°C for 16 hours and measure the OD of each well. 600 The minimum inhibitory concentration is the lowest antimicrobial peptide concentration at which bacterial growth is not seen. To determine the minimum bactericidal concentration (MBC), 10 μL of the suspension was taken from each well and spotted on an agar plate. The lowest peptide concentration that resulted in no growth of bacterial colonies was recorded as the MBC. This experiment was repeated 3 times, with 3 parallels each time.
[0039] The results are shown in Table 2. The MIC value of XWC26 against Bacillus cereus was 2 μg / mL, and its antibacterial ability was the most significant. The MIC values of XWC1, XWC7, XWC35, and XWC46 against Bacillus cereus were all 4 μg / mL, and their antibacterial abilities were better than those of the other antimicrobial peptides.
[0040] The minimum bactericidal concentration (MBC) of antimicrobial peptides (XWC1, XWC7, XWC26, XWC35, and XWC46) with MIC≤4μg / mL was further determined. The results are shown in Table 3. Except for the MBC value of antimicrobial peptide XWC7, which is twice as high as the MIC value, the MBC values of the other four peptides are consistent with their MIC values. The experiment showed that the above antimicrobial peptides have strong antibacterial activity against Bacillus cereus.
[0041] Table 2 MIC of XWC1-AMP50 against Bacillus cereus (μg / mL)
[0042]
[0043]
[0044] Table 3 MBC (μg / mL) of antimicrobial peptide XWC1 and others against Bacillus cereus
[0045]
[0046] Example 4: Antimicrobial spectrum determination
[0047] The antimicrobial activity of the antimicrobial peptides (XWC1, XWC7, XWC26, XWC35, XWC46) with MIC ≤ 4 μg / mL in Example 3 was determined, and the antimicrobial activity against Gram-positive bacteria (such as Staphylococcus aureus) and Gram-negative bacteria (such as Escherichia coli) was evaluated.
[0048] Each test strain was streaked onto a non-anti-MH solid medium and incubated at 37°C for 16 hours. 3 to 5 colonies were selected and inoculated into 3 mL of MH liquid medium for overnight culture. The next morning, the OD of the bacterial solution was measured using a spectrophotometer. 600 value and diluted it to 5 × 10 5 CFU / mL. Take 90μL of the diluted bacterial solution and add it to a 96-well plate. Dilute the antimicrobial peptide according to the two-fold dilution method and take 10μL of each well and add them to the 96-well plate containing the bacterial suspension. The final concentrations are 128μg / mL, 64μg / mL, 32μg / mL, 16μg / mL, 8μg / mL, 4μg / mL, 2μg / mL, 1μg / mL, 0.5μg / mL, and 0.25μg / mL. Ampicillin is used as a control. Place the 96-well plate in an incubator at 37°C for 16 hours and measure the OD of each well. 600 The minimum inhibitory concentration is the lowest concentration of antimicrobial peptide at which bacterial growth is not observed. This experiment was repeated 3 times, with 3 parallels each time.
[0049] The results are shown in Table 4, which show stronger antibacterial activity against the tested Gram-positive bacteria (such as Staphylococcus aureus, Bacillus subtilis, etc.) than Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, etc.). The experiment shows that the above antimicrobial peptides have a wide range of antibacterial activity, and the effect is stronger against Gram-positive bacteria.
[0050] Table 4 Antimicrobial spectrum determination of antimicrobial peptide XWC1
[0051]
[0052] Example 5: Observation of the cell morphology of Bacillus cereus before and after the action of antimicrobial peptide XWC26
[0053] Bacillus cereus ATCC14579 was inoculated into antibiotic-free LB liquid medium and cultured overnight. The next morning, the OD of the bacterial solution was measured using a spectrophotometer. 600 value and diluted it to 1×10 8 CFU / mL, add antimicrobial peptide XWC26 to a final concentration of 2×MIC, use PBS as a negative control, incubate at 37°C for 1h, then centrifuge at 8000rpm for 3min, discard the supernatant, wash the bacteria three times with PBS buffer, add 3% (v / v) glutaraldehyde, and fix overnight at 4°C. After sufficient fixation, centrifuge at 8000rpm for 5min, wash three times with PBS buffer, and then dehydrate with ethanol solutions with volume fractions of 30%, 50%, 70%, 80%, and 90% in sequence, 15min each time, and dehydrate with 100% ethanol twice. Then perform critical point drying, spray gold with an ion sputtering instrument, and observe the morphology of the bacteria under a scanning electron microscope.
[0054] The scanning electron microscopy results are as follows Figure 1 As shown in the figure, the cells of Bacillus cereus without peptide treatment had normal morphology, intact cell membrane and smooth surface. However, after treatment with antimicrobial peptide XWC26, the bacterial membrane surface changed significantly, becoming wrinkled and rough, with obvious membrane rupture and cytoplasmic component leakage. The experiment showed that the antimicrobial peptide XWC26 can destroy the cell membrane of Bacillus cereus, change the permeability of the cell membrane, and ultimately lead to bacterial death.
[0055] Example 6: Antimicrobial peptides inhibit spore germination of Bacillus cereus
[0056] Bacillus cereus ATCC14579 was inoculated in an antibiotic-free LB liquid medium. After 48 hours of culture, 100 μL of the diluted bacterial solution was spread on the spore medium for 5 days. Then the cells were scraped from the culture plate and washed 3 times with PBS buffer, centrifuged at 4000 rpm for 20 minutes and resuspended in PBS buffer. The spore suspension was fully killed by placing it in an 80°C water bath for 10 minutes, and then washed 3 times with PBS buffer to remove the nutrient cells. The spore suspension was diluted with an appropriate amount of LB medium. 200 μL of spore suspension and 200 μL of peptide solutions of different concentrations were added to a 96-well plate. After overnight incubation, 10 μL of the sample was diluted and spread. After 16 hours of incubation in the incubator, the plate was counted, and the plate without antimicrobial peptide was used as a control. This experiment was repeated 3 times, with three replicates each time.
[0057] like Figure 2As shown, compared with the untreated control, the spore germination rate of Bacillus cereus spores was 75% after the antimicrobial peptide XWC26 concentration was 2 μg / mL. As the concentration increased to 8 μg / mL, the spore germination rate decreased to 15%. When the concentration increased to 16 μg / mL, the spore germination rate was less than 10%. The experiment showed that the antimicrobial peptide XWC26 at a high concentration can effectively inhibit the germination of Bacillus cereus spores.
[0058] Example 7: Antimicrobial Peptide Stability Determination
[0059] Thermal stability test: The antimicrobial peptides (XWC1, XWC7, XWC26, XWC35, XWC46) were placed at 25, 50, 75 and 100℃ for 1h, then returned to room temperature, and their MICs against Bacillus cereus were measured. Untreated antimicrobial peptides (4℃) were used as controls. The test was repeated 3 times, with 3 parallels each time.
[0060] Acid-base stability assay: The pH value of the buffer solution was 2 (50 mM, glycine-HCl buffer), 6 (50 mM, sodium phosphate buffer) or 10 (50 mM, glycine-NaOH buffer). The above antimicrobial peptides were dissolved in the buffer solution and incubated at 37°C for 1 hour to determine their MIC against Bacillus cereus. The antimicrobial peptides dissolved in PBS buffer were used as controls. The test was repeated 3 times, with 3 parallels each time.
[0061] Protease stability assay: Pepsin, trypsin and proteinase-K were dissolved in PBS buffer to a final concentration of 20 μg / mL. The above antimicrobial peptides were mixed with the above proteases at a volume ratio of 1:1 at 37°C for 1 hour. Then, the peptide-protease mixture was heated at 60°C for 15 minutes to inactivate the protease activity. The MIC against Bacillus cereus was determined, and the antimicrobial peptides mixed in PBS buffer were used as a control. The test was repeated 3 times, with 3 parallels each time.
[0062] Table 5 shows the temperature tolerance results. It can be found from the table that the activities of the above five antimicrobial peptides remain unchanged after being treated at a temperature as high as 100°C, indicating that the above antimicrobial peptides have good thermal stability and can withstand heat treatment during food processing.
[0063] Table 6 shows the acid-base tolerance results. The antibacterial activity of XWC7 is not affected by pH changes. XWC1, XWC26, XWC35, and XWC46 maintain antibacterial activity at pH 2-6, and their activity decreases slightly at pH 10, indicating that the antimicrobial peptides have good stability under acidic and neutral conditions. In alkaline conditions, precipitation will occur due to reaching the isoelectric point of the protein, resulting in the antibacterial activity being affected to a certain extent.
[0064] Table 7 shows the results of protease resistance. The activities of XWC1, XWC26, XWC35, and XWC46 remained unchanged under the influence of pepsin, while the activity of XWC7 was slightly reduced. Under the influence of trypsin or proteinase-K, the activities of the above antimicrobial peptides decreased by 8 to 16 times, indicating that the above antimicrobial peptides maintained good stability in the presence of pepsin, but had poor stability in the presence of trypsin and / or proteinase-K.
[0065] Table 5 Determination of temperature tolerance of antimicrobial peptide XWC1
[0066]
[0067] Table 6 Determination of acid-base tolerance of antimicrobial peptide XWC1
[0068]
[0069] Table 7 Determination of protease resistance of antimicrobial peptide XWC1
[0070]
[0071] Example 8: Determination of hemolytic activity of antimicrobial peptides
[0072] Take 100 μL of 6% (v / v) mouse erythrocyte suspension (Shanghai Yuanye) and add it to a 96-well plate, then add 100 μL of different concentrations of antimicrobial peptides (XWC1, XWC7, XWC26, XWC35, XWC46) to a final concentration of 1-128 μg / mL, and take the same amount of PBS and 1% (v / v) Triton X-100 as negative control group and positive control group respectively. Incubate the 96-well plate at 37°C for 1 hour, centrifuge at 1000 r / min for 3 minutes, take the supernatant to a new 96-well plate, and measure the OD of each well. 540 nm value, and calculate the hemolysis rate. The hemolysis rate calculation formula is as follows: Hemolysis rate (%) = (sample OD 540 nm-negative control OD 540 nm) / (positive control OD 540 nm-negative to OD 540 nm)×100
[0073] Figure 3 The above antimicrobial peptide hemolytic activity changes with concentration. It can be seen from the figure that the antimicrobial peptide has almost no hemolytic activity within the range below 2μg / mL. When the concentration is increased to 4μg / mL, it begins to show hemolytic activity, and when it increases to 8μg / mL, it shows obvious hemolytic activity, and the hemolytic rate is higher than 10%. This shows that the above antimicrobial peptide has a relatively stable biosafety at its minimum inhibitory concentration (MIC≤4μg / mL), but it still needs to be improved.
[0074] Embodiment 9: Application example of the embodiment in food
[0075] Cooked rice was selected as the experimental object to study the antimicrobial peptide XWC26's antiseptic effect in food. The rice sample was taken from the student cafeteria and heated in a microwave oven at high temperature for 3 minutes to kill the microorganisms. 10g of cooked rice was diluted with 40mL of distilled water and shaken for 10 minutes. Then, 5×10 5 Rice samples were artificially contaminated with Bacillus cereus at 100 CFU / mL and placed at 25°C for 1 hour. Antimicrobial peptides were added to the samples to a final concentration of 8 μg / mL and incubated at 25°C for 3 hours. The samples without antimicrobial peptides were used as controls. Samples were taken every 1 hour, diluted and spread. The plates were incubated at 37°C for 16 hours and the average number of colonies was counted. This experiment was performed 3 times.
[0076] The results are as follows Figure 4 As shown, the sample treated with antimicrobial peptide XWC26 decreased by about 2 orders of magnitude within 2 hours, indicating that it can inhibit and kill bacteria in rice samples in a short period of time and can be used for food preservation.
[0077] The above embodiments are only preferred implementation modes of the present invention and are only used to explain the present invention rather than to limit the present invention. Any changes, substitutions, modifications, etc. made by those skilled in the art without departing from the spirit of the present invention should fall within the scope of protection of the present invention.
Claims
1. Antimicrobial peptides against Bacillus cereus, Features: The amino acid sequence formula of the anti-Bacillus cereus antimicrobial peptide is [KR]GG[KR]XC[FWY]C[KR]X[KR][FWY]C[LIAV]CXG[KR][KR].
2. The anti-Bacillus cereus antimicrobial peptide according to claim 1, Features: The expression [KR] in brackets means that lysine and arginine are also acceptable at the first, fourth, ninth, eleventh, eighteenth, and nineteenth positions in the grammar; [FWY] means that phenylalanine, tryptophan, and tyrosine are also acceptable at the seventh and twelfth positions in the grammar; and [LIAV] means that leucine, isoleucine, alanine, and valine are also acceptable at the fourteenth position in the grammar.
3. The anti-Bacillus cereus antimicrobial peptide according to claim 1, Features: The amino acid sequence of the anti-Bacillus cereus antimicrobial peptide is as follows:
4. The anti-Bacillus cereus antimicrobial peptide according to claim 1, Features: The molecular weight of the anti-Bacillus cereus antimicrobial peptide is in the range of 1907.36-2583.08 Da, the isoelectric point is in the range of 9.62-11.31, and the net charge number is in the range of 6-8.
5. The anti-Bacillus cereus antimicrobial peptide according to claim 1, It is characterized in that One of the synthetic antimicrobial peptides, XWC26, has an amino acid sequence formula of KGGKLCWCKNKWCICLGKR, a molecular weight of 2224.79 Da, an isoelectric point of 9.70, and a net charge of 6.
6. The method for synthesizing the antibacterial peptide against Bacillus cereus according to any one of claims 1 to 5, wherein the peptide having the amino acid sequence of the target product is synthesized by using CTC resin as a solid phase carrier and Fmoc solid phase synthesis method.
7. Use of the anti-Bacillus cereus antimicrobial peptide according to any one of claims 1 to 5 in inhibiting the activity of Bacillus cereus and inhibiting the germination of Bacillus cereus spores.
8. Use of the anti-Bacillus cereus antimicrobial peptide according to claim 1 in the preparation of microbial inhibitors.
9. The use according to claim 8, Features: The microbial inhibitor is a food preservative, a cosmetic preservative or a drug for preventing and treating bacterial infection.
10. The use according to claim 8, Features: The microorganisms are Bacillus cereus, and other Gram-positive bacteria and Gram-negative bacteria.
Citation Information
Patent Citations
Bacillus cereus ATP synthase beta subunit antibacterial peptide BaD9 and application thereof
CN116622670A
KR20240115407A
Cited By
Antimicrobial peptide against bacillus cereus, preparation method therefor and use thereof
WO2026036441A3
